Nmazuo Ozuah
Overview
Explore the profile of Nmazuo Ozuah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chirande L, Chirande L, Namazzi R, Hockenberry M, Wasswa P, Kiguli S, et al.
Blood Adv
. 2024 Dec;
9(4):939-947.
PMID: 39631074
The spectrum of hematological diseases in African children includes anemias, bleeding disorders, thromboses, and oncological diseases such as leukemias. Although data are limited, outcomes for these diseases are poorer in...
2.
Manase F, Silverstein A, Kamiyango W, Villiera J, Dziwe C, Wallrauch C, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594724
Background/objectives: Kaposi sarcoma (KS) is a common lymphatic endothelial cancer among children with and without HIV in central and eastern Africa. Despite its clinical heterogeneity, its various clinical phenotypes are...
3.
Mzikamanda R, Chinthambi M, Tomoka T, Mbutuka H, McAtee C, Dreyer Z, et al.
Pediatr Blood Cancer
. 2024 Oct;
72(1):e31379.
PMID: 39387387
No abstract available.
4.
Brown B, Pryor W, Nandi B, Mapurisa A, McAtee C, Ozuah N, et al.
J Am Coll Radiol
. 2024 Aug;
21(11):1805-1809.
PMID: 39117185
No abstract available.
5.
Gastier-Foster J, Lutwama F, Mbabazi O, Mlenga S, Ulaya K, Namazzi R, et al.
Front Oncol
. 2024 Jun;
14:1426638.
PMID: 38939333
Risk stratification and molecular targeting have been key to increasing cure rates for pediatric cancers in high-income countries. In contrast, precise diagnosis in low-resource settings is hindered by insufficient pathology...
6.
Lubega J, Chirande L, Atwine B, Davidson A, Kashaigili H, Kanyamuhunga A, et al.
Lancet Oncol
. 2023 Jul;
24(7):729-732.
PMID: 37414010
No abstract available.
7.
Holmes D, Matatiyo A, Mpasa A, Huibers M, Manda G, Tomoka T, et al.
Pediatr Blood Cancer
. 2023 Feb;
70(5):e30242.
PMID: 36798020
Introduction: Wilms tumor therapy in low- and middle-income countries (LMICs) relies on treatment protocols adapted to resource limitations, but these protocols have rarely been evaluated in real-world settings. Such evaluations...
8.
Wachepa S, Bvalani R, Namubiru T, Namugerwa S, Kaudha G, Mpasa A, et al.
Pediatr Blood Cancer
. 2022 Jul;
69(10):e29876.
PMID: 35856744
Background: Sickle cell disease (SCD) is characterized by both acute and chronic complications that affect the daily lives of patients and lower their quality of life. Objective: To describe the...
9.
Gondwe Y, Salima A, Manda A, Ozuah N, Mapurisa G, Brandt K, et al.
Pediatr Blood Cancer
. 2022 Jun;
69(10):e29867.
PMID: 35731580
Background: Burkitt lymphoma (BL) accounts for 90% of pediatric lymphomas in sub-Saharan Africa. Plasmodium falciparum malaria is considered an etiological factor of BL. We describe the geographic distribution of pediatric...
10.
Silverstein A, Butia M, Bank R, Manda G, Nyasulu C, Mwango N, et al.
J Pain Symptom Manage
. 2022 Jan;
63(5):e473-e480.
PMID: 35031502
Context: Outcomes for children with cancer in sub-Saharan Africa (SAA) are dismal due to delayed diagnosis and limited access to curative therapy. When establishing a pediatric hematology-oncology (PHO) program in...